Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-62.79%
operating margin TTM
-50.35%
revenue TTM
98.33 Million
revenue per share TTM
1.97$
valuation ratios | |
|---|---|
| pe ratio | -2.69 |
| peg ratio | -0.06 |
| price to book ratio | -10.88 |
| price to sales ratio | 1.70 |
| enterprise value multiple | -0.07 |
| price fair value | -10.88 |
profitability ratios | |
|---|---|
| gross profit margin | 63.87% |
| operating profit margin | -50.35% |
| pretax profit margin | -62.69% |
| net profit margin | -62.79% |
| return on assets | -21.17% |
| return on equity | -2796.13% |
| return on capital employed | -418.74% |
liquidity ratios | |
|---|---|
| current ratio | 0.61 |
| quick ratio | 0.40 |
| cash ratio | 0.19 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 607.84 |
| operating cycle | 720.67 |
| days of payables outstanding | 273.72 |
| cash conversion cycle | 446.96 |
| receivables turnover | 3.23 |
| payables turnover | 1.33 |
| inventory turnover | 0.60 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.74 |
| debt equity ratio | -14.22 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 1.08 |
| interest coverage | -3.77 |
| cash flow to debt ratio | -0.12 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.23 |
| cash per share | 0.55 |
| operating cash flow per share | -0.21 |
| free cash flow operating cash flow ratio | 1.12 |
| cash flow coverage ratios | -0.12 |
| short term coverage ratios | -0.13 |
| capital expenditure coverage ratio | -8.18 |
Frequently Asked Questions
When was the last time Akoya Biosciences, Inc. (NASDAQ:AKYA) reported earnings?
Akoya Biosciences, Inc. (AKYA) published its most recent earnings results on 13-05-2025.
What is Akoya Biosciences, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Akoya Biosciences, Inc. (NASDAQ:AKYA)'s trailing twelve months ROE is -2796.13%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Akoya Biosciences, Inc. (AKYA) currently has a ROA of -21.17%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did AKYA's net profit margin stand at?
AKYA reported a profit margin of -62.79% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is AKYA's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.61 in the most recent quarter. The quick ratio stood at 0.40, with a Debt/Eq ratio of -14.22.